.jpg "Image treatment")
Market Highlights
- Overall vacancy stands at 37.8%, down 170 basis points (bps) quarter over quarter but still up 300 bps year over year, indicating continued market softening despite modest short term improvement.
- Global biotherapeutics leader CSL announced a nearly $1.5 billion investment to expand its Kankakee biotherapeutics manufacturing campus, with completion expected in 2031, creating 300 jobs and retaining over 1,200.
- 32 Biosciences raised $42.0 million in Series A funding to advance its lead drug candidate and expand its broader pipeline and research platform.